VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
Management of Acute psychosis emergency to stabilisaton
1. MANAGING ACUTE PSYCHOTIC
EPISODE
Dr. Jayaprakashan K P
Associate Professor of Psychiatry,
Govt. Medical College, Thiruvananthapuram
FROM EMERGENCY TO STABILISATION
2. Acute behavioural disturbance
■ psychiatric illness -only one
cause
■ physical illness
– acute confusional state
– intoxication,
– head injury,
– epilepsy, infection,
– metabolic disturbance
– hypoglycaemia
■ substance abuse
■ Personality disorder
3. PSYCHOSIS
Common reason for
presentation to ED
Serious disturbance behaviour
Loss of reality orientation
Delusions /hallucinations/
disorganised speech or
behaviour/catatonia
Diagnosis may vary …
4. Treatment goals PE
Zeller SL Primary Psychiatry. Vol 17. No 6.2010.
Exclude medical etiologies for symptoms
•Rapid stabilization of acute crisis
Avoid coercion
•Treat in the least restrictive setting
Form a therapeutic alliance
•Appropriate disposition and aftercare plan
5. Indicators for medical
problem
■ Somatic complaints
■ Vital sign abnormalities
■ Physical signs
■ Signs of intoxication,
■ Disorientation,
■ Rapid onset of psychotic
symptoms, or
■ A waxing and waning
mental status
(Allen MH (ed): Emergency Psychiatry (Review of Psychiatry Series; Oldham JM and Riba MB, series eds).
Washington, DC, American Psychiatric Publishing, 2002
6. Investigations
■ Complete blood count
■ Metabolic profile
■ Drug and alcohol levels
■ TSH etc..
■ First episode – more
detailed investigations
7. Thorough workup
■ First episode psychosis
■ Elderly patients, and
■ Patients with a history of
trauma, falls
■ Patients with medical
comorbidities
Whenever possible should be done before giving psychotropics
8. Referral from a general
hospital ED
■ Delirium and other
organic conditions may
be missed
■ In patients with
psychiatric diagnosis
– Delirium is missed
– Medical conditions
are missed.
9. Initial
assessment
At first sight
Capacity for consent
Potential harm to self and others
RISK ASSESSMENT
Whether immediate intervention
is needed
RAPID TRANQUILISATION
vs
DETAILED EVALUATION
10. How they came
■ Came on their own
■ Brought by a relative
■ Referred from a family doctor
or physician
■ Brought by police
11. Brought involuntarily
■ Adequate staff should be
available
■ Assess with support staff
in the room
■ Safe environment
■ Brought restrained
– physical examination
– assess the need to
continue
– Use less stigmatising
methods
12. Immediate assessment
THOSE WHO ARE
■ frightened or paranoid,
■ verbally responding to
internal stimuli,
■ verbally aggressive or
threatening,
■ psychomotor agitation
(e.g., pacing or
shadowboxing),
■ attempting to leave the
area without being
evaluated.
13. Risk assessment
■ Predictors of aggression
– Past history
– Intoxication
– Recent threatening
behavior
■ Assessment tools
– Eg. HCR -20
Monahan J, Steadman HJ, Silver E, et al: Rethinking Risk Assessment: The MacArthur
Study of Mental Disorders and Violence. New York, Oxford University Press, 2001
14. RAPID TRANQUILISATION
■ Calming the patient
without much sedation
– NON-PHARMACOLOGICAL
– PHARMACOLOGICAL
■ NICE Guidelines RT
“All medication given in the
short-term management of
disturbed/violent behaviour
should be considered as part of
rapid tranquillisation”
15. Rapid Tranquillisation (RT)
■ No strong evidence base-
based on
– Partly on research
data
– Theoretical
considerations
– Clinical experience
16. STEP 1-Nonpharmacological
■ Offering food/ drink or
cloth
■ Directing to quiet/secure
area
■ Distraction
■ Negotiation
■ De- escalation
The management of violence in general Psychiatry Sophie E. DavisonAdvances in Psychiatric Treatment (2005), vol. 11.
http://apt.rcpsych.org/
17. De-escalation/talking down
■ Assessment of the
immediate situation;
■ Verbal and non-verbal
communication designed
to facilitate cooperation;
■ Problem-solving tactics
Dix, R. (2001) De-escalation techniques. In Psychiatric Intensive Care (eds D. Beer, S. Pereira & C. Paton)
18. Time out
■ Patient is voluntarily
moved to a less
stimulating area
■ Different from seclusion
19. STEP 2- Oral
■ Roughly 30mins, may be
longer
■ Affected by food
■ Can use MD/SL /liquids
■ Repeat doses after
minimum 30mins
■ Standard oral doses of
antipsychotics or
benzodiazepines or both
Rapid Tranquillisation (RT) PolicyApproval date September 2013, Executive Director – Quality & Medical Leadership,
Hertfordshire Partnership, University NHS Foundation Trust
20. STEP 3 - Parenteral
■ Parenteral (IM):
– Quicker onset of
action
– approx 15-30mins
– Affected by blood
perfusion
– IV Generally
avoided
■ Repeat after 30mins if
necessary
Rapid Tranquillisation (RT) PolicyApproval date September 2013, Executive Director – Quality & Medical Leadership,
Hertfordshire Partnership, University NHS Foundation Trust
23. Ideal parenteral antipsychotic
■ Rapid onset of therapeutic
effect
■ Calming without profound
sedation
■ Low risk of acute movement
disorders
■ Low risk of hypotension
■ No dysphoria
■ Effective and well-tolerated
■ Transition from intramuscular
to oral/depot available
Zimbroff DL. CNS Spectr. Vol 8, No 11 (Suppl 2). 2003
24. Use of atypical antipsychotic
■ Several RCT s supporting oral atypical APDs
■ Larger, placebo-controlled RCTs support the efficacy of IM
olanzapine, ziprasidone, and aripiprazole
■ Studies are in moderately disturbed Pts
■ Efficacy and safety of combination APD not known
■ Aripiprazole less effective but Benzodiazepines can be co-
administered.
Villari V et alCitrome L. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a
quantitative review of efficacy and safety. J Clin Psychiatry 2007; 68:1876–1885.
Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Prog Neuropsychopharmacol
Biol Psychiatry 2008; 32:405–413.
25. Haloperidol
■ Cochrane
– Effective alone but poorly
tolerated
– Co-administration of PM
■ NICE
– Evidence of promethazine
is inconclusive
■ Rapid Tranquilisation Clinical
Trial (TREC )
26. TREC studies
1. Brazil, 2003 (BMJ). n=301.
IM Midazolam vs. IM HPL+PM
Tranquil/sedated at 20mins.
2. India, 2004 (BJPsych). n=200.
IM lorazepam vs. IM HPL+PM
Tranquil/calm or asleep by 4hrs
3. Brazil, 2007 (BMJ). n=316.
IM Haloperidol vs. IM HPL+PM
Tranquil/asleep at 20mins.
4. India, 2007 (BMJ). n=300.
IM olanzapine vs. IM HPL+PM
Tranquil/asleep at 15mins
27. Case against HPL
■ EPS and acute dystonia(5%)
■ QT Prolongation (15 ms)
■ Pre- treatment ECG
■ Seizures (rare)
■ Combination not
recommended
■ PM inhibit metabolism
The Maudsley Prescribing Guidelines in Psychiatry, 12th Edition, David Taylor, Carol
Paton, Shitij Kapur, April 2015, Wiley-Blackwell
28. Haloperidol
NHS /NICE Guideline
■ 10mg po = 6mg IM - no longer licensed for IV use
■ Baseline ECG is recommended prior to treatment in all
patients,
■ ECG monitoring in the elderly and patients with a positive h/o
cardiac problems
■ Discontinue if the QTc exceeds 500ms.
■ BNF maximums now 20mg/d po, 12mg/d IM
29. DOSE
■ High dose (more than
10mg HPL or equivalent)
– Not more effective
– More adverse
effects
■ Low dose HPL - equally
effective
30. Olanzapine IM
■ Action IM: 15-30mins (po: ~ 2
hours)
■ t½: 30 hours, duration of
effect: ~24 hours Dose: 10mg.
Po = IM - Inj must be at least 2
hrs apart,
■ Max 3 inj or 20mg/24hrs all
routes
■ Cardiorespiratory depression,
Simultaneous injection of
benzodiazepine is not
recommended.
31. Ziprasidone Injection
■ 10 mg–20 mg IM
■ maximum dose of 40 mg
per day.
■ 10 mg -every 2 hours
■ 20 mg every 4 hours
Not
available
32. Aripiprazole Injection
■ Onset of action IM: 30-
45mins (slower)
■ Dose: (5.25mg) 9.75mg =
1.3mls, (15mg )
■ Inj must be at least 2 hrs
apart
■ max. 3 inj or 30mg/24hrs
all routes
■ With concurrent
benzodiazepines
■ Less effective than
haloperidol
Not
available
33. Benzodiazepines
■ Diazepam
– Not well absorbed as IM
■ Lorazepam
– Short acting, rapid onset
– No active metabolite- low risk of
accumulation
– t½ : 12-16 hours , duration effect: 6-8 hours
– 2mg IM repeated 6hrly
■ Inj Midazolam 7.5 to 10mg IM
■ Risk of respiratory depression. Inj.
Flumazenil should be available.
35. Role of Clopixol Acuphase
■ Zuclopenthixol Acetate
■ Not for Rapid Tranquillisation
■ Onset of action at 2-8 hours
■ Maximum serum concentrations
reached at 24-36 hours
■ Medium term plan – allow less
restraint
36. Alternative RT Options
ECT
■ Depressive disorder/ Mania/ Acute
Schizophrenia
Loading dose of Valproate
■ Mania, short term response to
aggression in schizophrenia
Midazolam – buccal & sublingual
■ Sublingual: high bioavailability
(~75%) reliable plasma concs2
■ Sedative effects at 15 minutes
peaking at 30 minutes, and lasted at
least 1 hour
37. RT NEED TO BE JUDICIOUSLY COMBINED WITH
SECLUSION AND RESTRAINT
38. Restraint
■ Usually 4 point restraint
– Manual
– Mechanical
– Usually with strong
cotton gauze
– One upper limb
down
– Legs to opposite
side
40. Manual restraint
■ 5 persons
■ One person holding each
limb
■ Therapeutic hold in
children
41. Gravitational restraint
■ Reclining chair like
positioning
■ For medically ill and
agitated
■ Lighter restraint of limbs
O'Brien EM1, Rosenquist PB, Kimball JN, Minor LN, Arias LM. A novel positioning technique for the agitated patient
after electroconvulsive therapy: gravitational restraint J ECT. 2010 Sep;26(3):158
42. Complications
death injures
Should be rigorously monitored – implemented for the shortest
period
Currier GW, Allen MH. Emergency psychiatry: physical and chemical restraint in the psychiatric emergency service.
Psychiatr Serv. 2000;51:717-719
43. Seclusion
Seclusion refers to the temporary, involuntary confinement of a
patient in a room or area from which the person is physically
prevented from leaving
44. Monitoring
■ 1 hour rule
■ should be monitored by
„within eyesight‟
observation by a suitably
trained individual
■ Record keeping
47. The aims of RT are threefold
:
1. To reduce suffering for the patient: psychological or physical
(through self-harm or accidents)
2. To reduce risk of harm to others by maintaining a safe
environment
3. To do no harm (by prescribing safe regimes and monitoring
physical health).
48. Detailed evaluation
■ Diagnosis and specific
treatment at the point
when reached specific
diagnosis
– Schizophrenia
– Other Psychotic
disorders
– Psychotic
depression
– Mood Disorder
53. Pharmacological Management
■ Safety first
– Oral if possible/ atypical
– lower dose of Haloperidol/ atypical where affordable
■ Reduce complications
– ECG/ blood level monitoring/ frequent evaluation
■ Reduce direct or indirect harm
– Judicious combination with seclusion and restraint
54. Immediate need
■ Setting up ED with a
design focussed on
patient staff safety
■ A written seclusion and
restraint policy
■ Developing staff training
and team work in ED
55. Psychiatric Emergency
Rooms
Modern psychiatric emergency
room in general hospital ED
Collapsible wall converting the
room into a ligature proof safe
room
Emory-ED-Behavioral-Health-Exam-Room-2-tamper-proof
57. Set up safe facility
Safe environment
Cell rooms to modern seclusion rooms
Trained staff in adequate number
Mental Health Care and Human Rights, 2008 Edited by D Nagaraja and Pratima Murthy Joint copyright: National
Human Rights Commission, New Delhi and National Institute of Mental Health and Neuro Sciences, Bangalore
58. POSITIVE & PROACTIVE CARE
■ Respect human rights
– Only few others can curtail basic rights of a citizen
■ There should be a continuous efforts at
– reducing seclusion and restraint
– at improving safety of hospital setting
– Improving basic facilities comfort for the client
– Improving staff skills and quality of care